Launch week offerEnds in00h00m00s

annual Promonthly Pro

Josep Nomdedeu

Has grant

Group leader

Hospital de la Santa Creu i Sant Pau

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain Professors in Cell Biology Cell Biology professors in Spain

Recent Grants

Grant: Close

New approaches to WT1 analysis in myeloid malignancies. Utility of single-cell studies.

Open Date: 2021-01-01

Close Date: 2023-12-01

Grant: Close

Hematologic Diagnosis SGR 2021 1212

Open Date: 2021-01-01

Close Date: 2025-09-01

Grant: Close

Immune response to COVID-19 in Hospital workers:identification of suitable donors for hyperimmune plasma therapy

Open Date: 2020-04-01

Close Date: 2020-12-01

Grant: Close

Clonal heterogeneity in acute myeloid leukemia:immunophenotypic and genotypic characterization. Patient derived xenografts(PDX).

Open Date: 2017-01-01

Close Date: 2019-12-01

Grant: Close

Hematologic Diagnosis SGR 2017 1395

Open Date: 2017-01-01

Close Date: 2021-12-01

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (16)

Miguel Arguello-Tomas

Josep Carreras Leukaemia Research Institute

SPAIN

View details

Oskar Marin-Bejar

Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

SPAIN

View details

Alessandra Giorgetti

Group Leader/Associate Professor

Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)

SPAIN

View details

Olga Salamero

SPAIN

View details

Julio Delgado

Head

Hospital Clínic de Barcelona

SPAIN

View details

Júlia Perera-Bel

Head of Bioinformatics Unit

Institut Hospital del Mar d'Investigacions Mèdiques

SPAIN

View details

Guillermo Ramil López

Hospital de la Santa Creu i Sant Pau

SPAIN

View details

Davide Crucitti

Instituto de Investigación Sanitaria de Santiago

SPAIN

View details

Pedro M. Quiros

Associate professor

University of Oviedo

SPAIN

View details

Pablo Menéndez Bujan

Scientific Director (Campus Clinic) / ICREA Research Professor

Josep Carreras Leukaemia Research Institute

SPAIN

View details

Ferran Navarro

Hospital de la Santa Creu i Sant Pau

SPAIN

View details

Aristi Damaskou

University of Cambridge

UNITED KINGDOM

View details

Daniel Wiseman

The University of Manchester

UNITED KINGDOM

View details

Carolina Martínez-Laperche

SPAIN

View details

Silvana Novelli

SPAIN

View details

María Isabel Hernández-Alvarez

Associate Professor and Group Leader

University of Barcelona

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Josep Nomdedeu

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (15)

Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy

SGK1 repression by WT1 may confer a survival advantage to leukemic cells under stress conditions.

D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-1.

Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis

CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia.

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification

Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection

Be aware of the X: <i>BCOR</i> mutations in myeloid neoplasms.

Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center

Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort

Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency.

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

Collaborators (16)

Miguel Arguello-Tomas

Oskar Marin-Bejar

Alessandra Giorgetti

Olga Salamero

Julio Delgado

Júlia Perera-Bel

Guillermo Ramil López

Davide Crucitti

Pedro M. Quiros

Pablo Menéndez Bujan

Ferran Navarro

Aristi Damaskou

Daniel Wiseman

Carolina Martínez-Laperche

Silvana Novelli

María Isabel Hernández-Alvarez

Make your next move.